(NASDAQ: MOLN) Molecular Partners Ag's forecast annual revenue growth rate of -4.56% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Molecular Partners Ag's revenue in 2024 is $7,997,727.On average, 2 Wall Street analysts forecast MOLN's revenue for 2024 to be $919,263,230, with the lowest MOLN revenue forecast at $88,706,602, and the highest MOLN revenue forecast at $1,749,819,858. On average, 2 Wall Street analysts forecast MOLN's revenue for 2025 to be $864,068,011, with the lowest MOLN revenue forecast at $36,139,727, and the highest MOLN revenue forecast at $1,691,996,296.
In 2026, MOLN is forecast to generate $112,361,696 in revenue, with the lowest revenue forecast at $13,141,719 and the highest revenue forecast at $211,581,673.